KoreaMed Synapse

1

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

Jihye Park

KMSID: 1516081360 Intest Res. 2022;20(1):1-2. Published online 2022 January 26 DOI: http://dx.doi.org/10.5217/ir.2021.00170

3

Management of inflammatory bowel disease in the COVID-19 era

Kyeong Ok Kim, Byung Ik Jang

KMSID: 1516081358 Intest Res. 2022;20(1):3-10. Published online 2021 February 3 DOI: http://dx.doi.org/10.5217/ir.2020.00156

11

Use of thiopurines in inflammatory bowel disease: an update

Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood

KMSID: 1516081357 Intest Res. 2022;20(1):11-30. Published online 2021 April 15 DOI: http://dx.doi.org/10.5217/ir.2020.00155

31

The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment

Sang Hoon Kim, Yun Jeong Lim

KMSID: 1516081359 Intest Res. 2022;20(1):31-42. Published online 2021 May 21 DOI: http://dx.doi.org/10.5217/ir.2021.00034

43

An integrative review of physical activity in adults with inflammatory bowel disease

Suja P. Davis, Patricia B. Crane, Linda P. Bolin, Lee Ann Johnson

KMSID: 1516081350 Intest Res. 2022;20(1):43-52. Published online 2021 January 22 DOI: http://dx.doi.org/10.5217/ir.2020.00049

53

The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom

Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi

KMSID: 1516081349 Intest Res. 2022;20(1):53-63. Published online 2021 January 6 DOI: http://dx.doi.org/10.5217/ir.2020.00079

64

Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study

Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood

KMSID: 1516081348 Intest Res. 2022;20(1):64-71. Published online 2021 February 3 DOI: http://dx.doi.org/10.5217/ir.2020.00100

72

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study

Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein

KMSID: 1516081352 Intest Res. 2022;20(1):72-77. Published online 2021 February 3 DOI: http://dx.doi.org/10.5217/ir.2020.00117

78

Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study

Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, Shinsuke Otagiri, Kana Yamanashi, Kazunori Nagashima, Reizo Onishi, Keiji Yagisawa, Haruto Nishimura, Takahiro Ito, Atsuo Maemoto, Naoya Sakamoto

KMSID: 1516081354 Intest Res. 2022;20(1):78-89. Published online 2021 January 22 DOI: http://dx.doi.org/10.5217/ir.2020.00124

90

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity

Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda

KMSID: 1516081353 Intest Res. 2022;20(1):90-100. Published online 2021 January 22 DOI: http://dx.doi.org/10.5217/ir.2020.00133

101

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg, Abhinav Vasudevan

KMSID: 1516081356 Intest Res. 2022;20(1):101-113. Published online 2021 March 12 DOI: http://dx.doi.org/10.5217/ir.2020.00146

114

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation

Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone

KMSID: 1516081361 Intest Res. 2022;20(1):114-123. Published online 2021 August 4 DOI: http://dx.doi.org/10.5217/ir.2021.00037

124

An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia

Nor Hamizah Shafiee, Nurul Huda Razalli, Norfilza M. Mokhtar, Eunice Tan, Raja Affendi Raja Ali

KMSID: 1516081347 Intest Res. 2022;20(1):124-133. Published online 2021 January 22 DOI: http://dx.doi.org/10.5217/ir.2020.00050

134

Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis

Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma

KMSID: 1516081351 Intest Res. 2022;20(1):134-143. Published online 2021 January 18 DOI: http://dx.doi.org/10.5217/ir.2020.00108

144

A case of autoimmune enteropathy with CTLA4 haploinsufficiency

Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Makoto Ooi, Nobuyuki Yamamoto, Suguru Uemura, Noriyuki Nishimura, Kazumoto Iijima, Keisuke Jimbo, Tsubasa Okano, Akihiro Hoshino, Kohsuke Imai, Hirokazu Kanegane, Ichiro Kobayashi, Yuzo Kodama

KMSID: 1516081346 Intest Res. 2022;20(1):144-149. Published online 2021 January 22 DOI: http://dx.doi.org/10.5217/ir.2020.00041

150

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report

Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige

KMSID: 1516081355 Intest Res. 2022;20(1):150-155. Published online 2021 March 12 DOI: http://dx.doi.org/10.5217/ir.2020.00148